Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Jimin Min

Matched on ORCID iD 0000-0002-2309-7875; OpenAlex author ID A5073386651. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
63
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 5 papers

Papers 9

  1. Spatially resolved tissue architecture and computational pathology in pancreatic cancer. Co-author DOI 10.1038/s12276-026-01782-4↗
  2. Metastatic pancreatic cancer: from human disease to preclinical modelling. Co-author DOI 10.1136/gutjnl-2025-336334↗
  3. AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors. Co-author DOI 10.1158/2159-8290.cd-25-1119↗
  4. CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. Co-author DOI 10.1186/s12943-026-02575-z↗
  5. Extra-lineage tissue programs define the transcription states of human pancreatic cancer Co-author DOI 10.64898/2026.04.29.721655↗
  6. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. First author DOI 10.1038/s41586-025-08927-x↗
  7. A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations Co-author DOI 10.1101/2025.06.20.660757↗
  8. TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Co-author DOI 10.1038/s41467-024-49189-x↗
  9. Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an ea… Co-author DOI 10.1101/2023.08.14.553002↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 9 shared papers, 2023–2026 · strength 2.13
  2. Seong-Woo Bae · 2 shared papers, 2026 · strength 0.65
  3. Vincent Bernard · 3 shared papers, 2025–2026 · strength 0.57
  4. Aristotelis Tsirigos · 1 shared paper, 2026 · strength 0.43
  5. Thomas C. Caffrey · 2 shared papers, 2025–2026 · strength 0.40
  6. Benson Chellakkan Selvanesan · 2 shared papers, 2025–2026 · strength 0.40
  7. Michael Anthony Hollingsworth · 2 shared papers, 2025–2026 · strength 0.40
  8. Paul M. Grandgenett · 2 shared papers, 2025–2026 · strength 0.40
  9. Peter Y. Yu · 1 shared paper, 2026 · strength 0.39
  10. Vasiliki Liaki · 1 shared paper, 2026 · strength 0.39
  11. Carmen E. Guerra · 1 shared paper, 2026 · strength 0.39
  12. Guangsheng Pei · 2 shared papers, 2025 · strength 0.35
  13. Robert A. Wolff · 2 shared papers, 2023–2025 · strength 0.31
  14. Fredrik I. Thege · 2 shared papers, 2023–2025 · strength 0.31
  15. Paola A. Guerrero · 2 shared papers, 2023–2025 · strength 0.31
  16. Andrew P. Feinberg · 1 shared paper, 2026 · strength 0.24
  17. Masahiro Maeda · 1 shared paper, 2026 · strength 0.24
  18. Barbara Stauch Slusher · 1 shared paper, 2026 · strength 0.24
  19. Huamin Wang · 1 shared paper, 2026 · strength 0.22
  20. Nina G. Steele · 1 shared paper, 2026 · strength 0.19
  21. Spring Holter · 1 shared paper, 2026 · strength 0.19
  22. Yuanchang Fang · 1 shared paper, 2026 · strength 0.19
  23. Hartland Warren Jackson · 1 shared paper, 2026 · strength 0.19
  24. Sabrina Ge · 1 shared paper, 2026 · strength 0.19
  25. Eugenia Flores Figueroa · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.